Drug shortage: Riluzole Oral Suspension (TEGLUTIK, TIGLUTIK)
FDA lists 4 presentations as Current. Availability: Unavailable (1), Available (3). Reason: Requirements related to complying with good manufacturing practices. Companies: EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.).
- Published by source
- 2024-01-26
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)
- Products
- Riluzole Oral Suspension TEGLUTIK TIGLUTIK
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Estimated recovery: TBD
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2024-01-26
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #881 | new | 2026-10-22 | 8e024f13cce6…17a2b0 | 6ecb8fe45958…7f6eb4 |
Chain head: #1076 8ad5adc30b9b…88ce20